Abstract
Background: SeDeM (Sediment Delivery Model) expert system is a preformulation tool employed for evaluating direct compression suitability of various excipients. SeDeM is a 12 parameters derived diagram and SeDeM-ODT (Sediment Delivery Model-Orodispersible tablets) is a 15 parameters derived diagram that can be used as a research tool for reducing the product development time. The best possible excipients for a specified pharmaceutical active ingredient could be screened for direct compression suitability.
Objective: SeDeM expert system has been successfully used and implemented for characterizing galenic properties of pharmaceutical excipients, direct compression suitability of excipients, development of ODT formulations, development of sustained-release formulations, and development of tablets of taste-masked drugs.
Conclusion: In the present review paper, the development and applications of SeDeM and SeDeMODT systems have been discussed in detail.
Keywords: SeDeM, SeDeM-ODT, direct compression, excipients, tablets, application.
Graphical Abstract
[http://dx.doi.org/10.1016/S1461-5347(99)00237-0] [PMID: 10664574]
[http://dx.doi.org/10.1016/0032-5910(76)80018-6]
[http://dx.doi.org/10.1007/s11095-007-9511-1] [PMID: 18185986]
[http://dx.doi.org/10.1016/j.ejpb.2009.07.001] [PMID: 19602435]
[http://dx.doi.org/10.5772/16540]
[http://dx.doi.org/10.3109/03639045.2012.756007] [PMID: 23343308]
[http://dx.doi.org/10.1016/j.ejpb.2006.06.008] [PMID: 16949262]
[http://dx.doi.org/10.1016/j.ejpb.2008.01.020] [PMID: 18367387]
[http://dx.doi.org/10.1016/j.powtec.2017.02.019]
[http://dx.doi.org/10.1080/10837450.2017.1342657] [PMID: 28612663]
[http://dx.doi.org/10.1016/j.powtec.2018.10.027]
[http://dx.doi.org/10.1016/j.powtec.2018.10.048]
[http://dx.doi.org/10.1080/10837450.2018.1435691] [PMID: 29394129]
[http://dx.doi.org/10.1208/s12249-019-1542-5] [PMID: 31712905]
[http://dx.doi.org/10.1016/j.ejpb.2019.09.003]
[http://dx.doi.org/10.1016/j.ejpb.2011.12.012] [PMID: 22245156]
[http://dx.doi.org/10.1016/j.powtec.2015.06.062]
[http://dx.doi.org/10.1080/10837450.2017.1345941] [PMID: 28657404]
[http://dx.doi.org/10.1515/acph-2017-0017] [PMID: 28590910]
[http://dx.doi.org/10.1016/j.ijpharm.2013.11.029] [PMID: 24284019]
[http://dx.doi.org/10.1016/j.jsps.2015.03.005] [PMID: 26903772]
[http://dx.doi.org/10.1016/j.ejps.2017.01.017] [PMID: 28108361]
[http://dx.doi.org/10.35333/jrp.2019.32]
[http://dx.doi.org/10.1208/s12249-019-1320-4] [PMID: 30746569]
[http://dx.doi.org/10.1016/j.ijpharm.2014.04.068] [PMID: 24792976]
[PMID: 22574511]
[http://dx.doi.org/10.3390/pharmaceutics12070674] [PMID: 32708961]
[http://dx.doi.org/10.1016/j.ijpharm.2015.01.011] [PMID: 25579868]
[http://dx.doi.org/10.1080/03639045.2019.1634094] [PMID: 31210544]
[http://dx.doi.org/10.1016/j.ejps.2019.03.028] [PMID: 30951825]
[http://dx.doi.org/10.1016/j.ejps.2019.06.003] [PMID: 31170527]
[http://dx.doi.org/10.1371/journal.pone.0196049] [PMID: 29689061]
[http://dx.doi.org/10.1016/j.jsps.2013.07.002] [PMID: 25473332]